Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 37, Issue 10, Pages 1808-1815Publisher
OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfab016
Keywords
glucocorticoids; in vitro model; in vivo model; nephrotic syndrome; podocytes
Categories
Funding
- Dutch Kidney Foundation [19OK005, 14A3D104, 15OKG16]
- Netherlands Organization for Scientific Research [091 501 61 81 01 36, 016.156.363]
Ask authors/readers for more resources
Glucocorticoids have been found to directly affect podocytes, promoting their recovery and limiting inflammatory responses, potentially having a positive impact on the treatment of nephrotic syndrome. Current research is primarily conducted using animal and cell models, but there are still limitations in fully replicating the human condition. New and promising models such as glomerulus-on-a-chip and kidney organoids have the potential to be developed into functional models for nephrotic syndrome in the future.
Nephrotic syndrome (NS) is characterized by massive proteinuria; podocyte loss or altered function is a central event in its pathophysiology. Treatment with glucocorticoids is the mainstay of therapy, however, many patients experience one or multiple relapses and prolonged use may be associated with severe adverse effects. Recently the beneficial effects of glucocorticoids have been attributed to a direct effect on podocytes in addition to the well-known immunosuppressive effects. The molecular effects of glucocorticoid action have been studied using animal and cell models of NS. This review provides a comprehensive overview of different molecular mediators regulated by glucocorticoids, including an overview of the model systems that were used to study them. Glucocorticoids are described to stimulate podocyte recovery by restoring pro-survival signalling of slit diaphragm-related proteins and limiting inflammatory responses. Of special interest is the effect of glucocorticoids on stabilizing the cytoskeleton of podocytes, since these effects are also described for other therapeutic agents used in NS, such as cyclosporin. Current models provide much insight but do not fully recapitulate the human condition since the pathophysiology underlying NS is poorly understood. New and promising models include the glomerulus-on-a-chip and kidney organoids, which have the potential to be further developed into functional NS models in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available